Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 876.56B | 822.93B | 815.27B | 710.94B | 631.81B |
Gross Profit | 381.59B | 333.11B | 319.59B | 307.32B | 286.60B |
EBITDA | 128.50B | 103.50B | 103.33B | 123.38B | 117.18B |
Net Income | 54.78B | 31.64B | 39.08B | 61.03B | 24.52B |
Balance Sheet | |||||
Total Assets | 932.65B | 896.11B | 850.49B | 811.15B | 743.90B |
Cash, Cash Equivalents and Short-Term Investments | 172.78B | 166.15B | 129.91B | 179.33B | 199.39B |
Total Debt | 600.00M | 37.71B | 37.42B | 40.83B | 57.46B |
Total Liabilities | 241.18B | 227.99B | 253.81B | 249.94B | 244.19B |
Stockholders Equity | 691.39B | 668.05B | 596.62B | 561.15B | 483.05B |
Cash Flow | |||||
Free Cash Flow | 54.24B | 93.54B | -28.05B | 36.41B | 81.75B |
Operating Cash Flow | 90.02B | 141.03B | 14.43B | 72.25B | 109.27B |
Investing Cash Flow | -48.15B | -42.07B | -32.20B | -40.78B | -25.08B |
Financing Cash Flow | -34.61B | -61.58B | -36.64B | -65.19B | -74.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥3.76T | 14.83 | 7.61% | 1.80% | 4.83% | 1.58% | |
74 Outperform | €413.93B | 20.78 | 7.98% | 2.27% | 3.27% | -12.28% | |
71 Outperform | ¥658.51B | 13.17 | 7.32% | 4.03% | 4.50% | 56.65% | |
69 Neutral | ¥755.73B | 17.00 | 4.52% | 2.84% | 7.62% | 8.47% | |
67 Neutral | €617.14B | 16.44 | 9.53% | 2.48% | 6.92% | 16.87% | |
64 Neutral | $10.64B | 16.01 | 5.48% | 2.12% | 2.72% | -24.90% | |
52 Neutral | $240.49B | ― | -16.55% | 0.96% | -7.37% | -653.50% |